Client News

Volta Medical Artificial Intelligence-Guided Cardiac Ablation Procedure Improves Treatment of Atrial Fibrillation

InflaRx Announces Pricing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

InflaRx Announces Public Offering of Ordinary Shares and Pre-Funded Warrants

Lindis Biotech and Pharmanovia Announce European Marketing Authorisation Approval for Catumaxomab, a First-in-Class Treatment for Malignant Ascites

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month

MIG Capital and CoreMedic Announce Fresh Funding in Series B Extension

Lotus Pharmaceutical Becomes Strategic Partner for the Commercialization of Formycon’s Eylea® Biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region

Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment

Affluent Medical Announces 10th Successful Human Implantation of its Artus Urinary Sphincter, Marking Completion of the Pilot Phase

Rentschler Biopharma Announces Atrategic Realignment of its Global Business Operations